Biocon informs about update

07 Jan 2025 Evaluate
Biocon has informed that it enclosed the company statement titled ‘Japan Health Authority (PMDA) Approves Biocon Biologics’ Ustekinumab BS, Biosimilar to J&J's Stelara®’. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

380.25 2.45 (0.65%)
16-Feb-2026 13:02 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1696.30
Dr. Reddys Lab 1270.00
Cipla 1350.65
Zydus Lifesciences 907.65
Lupin 2220.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×